The major activity in our laboratory is studies of DNA methylation in tumorigenesis, a process commonly observed in GC-rich sequences called CpG islands in many types of human cancers and is often associated with transcriptional silencing. Using non-Hodgkin's lymphoma (NHL) as a model system, our discovery-driven preliminary studies demonstrate that DNA hypermethylation is not a random event; many CpG island loci are susceptible to methylation alteration. As a result of this epigenetic mutation, the expression of genes that govern key functions of the cell may become silent, leading to clonal proliferation of tumor cells. Differential susceptibility of critical CpG island loci to DNA hypermethylation may therefore influence the development of different NHL subtypes and may help explain differences in tumor growth and treatment outcomes. We have identified several loci that are differentially methylated and may be involved in lymphomagenesis. Our Central Hypothesis: B-cell differentiation is affected by methylation of CpG islands and this frequently leads to silencing of gene transcription. We further hypothesize that 1) Histological classes of NHL actually contain more than one clinical disease; 2) Hypermethylation of CpG island loci in NHL cells can generate unique molecular signatures that are associated with clinical subtypes and; 3) Dissecting these complex epigenetic profiles requires an understanding of gene methylation in normal, as well as neoplastic, B-cell differentiation. This application will expand a current version of our Methylation-Specific Oligonucleotide (MSO) microarray, an invention that combines the power of the bisulfite treatment protocol with the versatility of oligonucleotide microarrays, and apply this innovative technique to study DNA methylation in cases of B-cell NHL and normal B-cells at similar stages of differentiation, and relate these changes to gene silencing and classification. We plan to test our hypotheses by pursuing 4 specific aims; 1. Generate an MSO microarray for analysis of promoter hypermethylation at about 4,000 loci in 80 genes; 2. Determine patterns of CpG island methylation that characterize subsets of NHL classes and their putative normal stage of B-cell differentiation; 3. Correlate the status of promoter hypermethylation defined by MSO with gene expression; 4. Develop and apply data management, analysis and visualization tools to decipher methylation profiles of NHL classes. The proposed studies are expected to yield important insights into potential mechanisms of DNA methylation-driven gene silencing related to B-cell differentiation and development of clinical subtypes of NHL.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA100055-04
Application #
7028951
Study Section
Special Emphasis Panel (ZRG1-CAMP (01))
Program Officer
Jessup, John M
Project Start
2003-04-16
Project End
2008-03-31
Budget Start
2006-04-01
Budget End
2008-03-31
Support Year
4
Fiscal Year
2006
Total Cost
$252,035
Indirect Cost
Name
University of Missouri-Columbia
Department
Pathology
Type
Schools of Medicine
DUNS #
153890272
City
Columbia
State
MO
Country
United States
Zip Code
65211
Bryan, Jeffrey N; Jabbes, Mohamed; Berent, Linda M et al. (2009) Hypermethylation of the DLC1 CpG island does not alter gene expression in canine lymphoma. BMC Genet 10:73
Rahmatpanah, Farahnaz B; Carstens, Stephanie; Hooshmand, Sam I et al. (2009) Large-scale analysis of DNA methylation in chronic lymphocytic leukemia. Epigenomics 1:39-61
Bennett, Lynda B; Schnabel, Jennifer L; Kelchen, Jean M et al. (2009) DNA hypermethylation accompanied by transcriptional repression in follicular lymphoma. Genes Chromosomes Cancer 48:828-41
Taylor, K H; Rahmatpanah, F; Davis, J W et al. (2008) Chromosomal localization of DNA methylation in small B-cell lymphoma. Leukemia 22:638-41
Shi, Huidong; Wang, Michael X; Caldwell, Charles W (2007) CpG islands: their potential as biomarkers for cancer. Expert Rev Mol Diagn 7:519-31
Taylor, Kristen H; Pena-Hernandez, Keila E; Davis, J Wade et al. (2007) Large-scale CpG methylation analysis identifies novel candidate genes and reveals methylation hotspots in acute lymphoblastic leukemia. Cancer Res 67:2617-25
Sjahputera, Ozy; Keller, James M; Davis, J Wade et al. (2007) Relational analysis of CpG islands methylation and gene expression in human lymphomas using possibilistic C-means clustering and modified cluster fuzzy density. IEEE/ACM Trans Comput Biol Bioinform 4:176-89
Shi, Huidong; Guo, Juyuan; Duff, Deiter J et al. (2007) Discovery of novel epigenetic markers in non-Hodgkin's lymphoma. Carcinogenesis 28:60-70
Taylor, Kristen H; Kramer, Robin S; Davis, J Wade et al. (2007) Ultradeep bisulfite sequencing analysis of DNA methylation patterns in multiple gene promoters by 454 sequencing. Cancer Res 67:8511-8
Taylor, K H; Liu, J; Guo, J et al. (2006) Promoter DNA methylation of CD10 in lymphoid malignancies. Leukemia 20:1910-2

Showing the most recent 10 out of 12 publications